-
Chardan Capital Reiterates Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Source: Buzz FX / 11 Feb 2025 07:37:10 America/Chicago
Chardan Capital Reiterates Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Arrowhead Pharmaceuticals ( NASDAQ:ARWR - Get Free Report ) 's stock had its "buy" rat
Read more...